[go: up one dir, main page]

DE69524358D1 - Trägerstoff zur verzögerten freisetzung - Google Patents

Trägerstoff zur verzögerten freisetzung

Info

Publication number
DE69524358D1
DE69524358D1 DE69524358T DE69524358T DE69524358D1 DE 69524358 D1 DE69524358 D1 DE 69524358D1 DE 69524358 T DE69524358 T DE 69524358T DE 69524358 T DE69524358 T DE 69524358T DE 69524358 D1 DE69524358 D1 DE 69524358D1
Authority
DE
Germany
Prior art keywords
carrier
delayed release
cross
heteropolysaccharide
linking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524358T
Other languages
English (en)
Other versions
DE69524358T2 (de
Inventor
Anand R Baichwal
Troy W Mccall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penwest Pharmaceuticals Co
Original Assignee
Mendell Edward Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Edward Co Inc filed Critical Mendell Edward Co Inc
Publication of DE69524358D1 publication Critical patent/DE69524358D1/de
Application granted granted Critical
Publication of DE69524358T2 publication Critical patent/DE69524358T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Superstructure Of Vehicle (AREA)
DE69524358T 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung Expired - Lifetime DE69524358T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
PCT/US1995/003825 WO1995028916A1 (en) 1994-04-25 1995-03-21 Sustained release excipient

Publications (2)

Publication Number Publication Date
DE69524358D1 true DE69524358D1 (de) 2002-01-17
DE69524358T2 DE69524358T2 (de) 2002-06-13

Family

ID=22873888

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69524358T Expired - Lifetime DE69524358T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung
DE69534575T Expired - Fee Related DE69534575T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten Freisetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69534575T Expired - Fee Related DE69534575T2 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten Freisetzung

Country Status (18)

Country Link
EP (2) EP1145712B1 (de)
JP (1) JP3279318B2 (de)
KR (1) KR100232020B1 (de)
CN (1) CN1131023C (de)
AT (2) ATE209906T1 (de)
AU (1) AU705378B2 (de)
CA (1) CA2164513C (de)
DE (2) DE69524358T2 (de)
DK (1) DK0706377T3 (de)
ES (2) ES2246961T3 (de)
FI (1) FI119353B (de)
HK (1) HK1040487B (de)
HU (1) HU219818B (de)
IL (1) IL113167A (de)
MX (1) MX9600022A (de)
PT (1) PT706377E (de)
TW (1) TW357085B (de)
WO (1) WO1995028916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
EP1404333A1 (de) 2001-07-06 2004-04-07 Endo Pharmaceuticals Inc. Kontrolliert freisetzende formulierungen von oxymorphon
JP2005523876A (ja) * 2001-09-26 2005-08-11 ペンウェスト ファーマシューティカルズ カンパニー 乱用の可能性が低減したオピオイド製剤
EP1499295A4 (de) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co Metoprolol-formulierungen mit verzögerter freisetzung
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
EP1145712B1 (de) 2005-11-02
KR100232020B1 (ko) 1999-12-01
DK0706377T3 (da) 2002-04-02
HU9503456D0 (en) 1996-02-28
EP0706377A1 (de) 1996-04-17
HK1040487B (zh) 2006-05-12
PT706377E (pt) 2002-05-31
JPH08512061A (ja) 1996-12-17
CN1127469A (zh) 1996-07-24
IL113167A0 (en) 1995-06-29
AU2198295A (en) 1995-11-16
AU705378B2 (en) 1999-05-20
HK1040487A1 (en) 2002-06-14
HUT73636A (en) 1996-08-28
FI956209L (fi) 1995-12-22
ES2164764T3 (es) 2002-03-01
ATE209906T1 (de) 2001-12-15
ATE308318T1 (de) 2005-11-15
KR960703016A (ko) 1996-06-19
FI956209A0 (fi) 1995-12-22
TW357085B (en) 1999-05-01
JP3279318B2 (ja) 2002-04-30
EP1145712A1 (de) 2001-10-17
CA2164513C (en) 1999-09-21
EP0706377B1 (de) 2001-12-05
DE69524358T2 (de) 2002-06-13
CA2164513A1 (en) 1995-11-02
MX9600022A (es) 1998-06-30
DE69534575T2 (de) 2006-07-13
DE69534575D1 (de) 2005-12-08
IL113167A (en) 2001-01-28
WO1995028916A1 (en) 1995-11-02
FI119353B (fi) 2008-10-31
CN1131023C (zh) 2003-12-17
ES2246961T3 (es) 2006-03-01
EP0706377A4 (de) 1996-11-06
HU219818B (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
GR3021551T3 (en) Pharmaceutical composition containing terbinafine as an anti-mycotic agent
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
IL112637A0 (en) A pharmaceutical composition containing oxybutynin and methods for the preparation thereof
HUT75881A (en) Pharmaceutical composition for 24 hour release of metoprolol
GB2263115B (en) Composition for dental restoration
SG28285A1 (en) Method for molding dental restorations and related apparatus
BR9609537A (pt) Composições farmacêuticas
HUP9900625A3 (en) Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
ZA915717B (en) Benzimidazoles,pharmaceutical compositions containing these compounds and processes for preparing them
UA32543C2 (uk) Арилацетаміди, що мають анальгетичну дію, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
FR2627984B1 (fr) Composition pulverulente a base d'alginate pour empreintes dentaires
GB2292153B (en) Silicone composition for dental impressions
EP0461586A3 (en) Dental composition for impression-taking
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
EP0476925A3 (en) Uv light-curable organopolysiloxane composition
ATE308318T1 (de) Trägerstoff zur verzögerten freisetzung
DE59109272D1 (de) Mehrkomponentenmaterial und Verfahren zu seiner Herstellung
IL99501A0 (en) Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA916570B (en) Desensitizing dental composition
ATA259590A (de) 3-(n-methyl-n-alkyl)-amino-2-methoxymethylenpro an-1-ol-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
FR2687068B1 (fr) Composition pour empreintes dentaires.
ITMI940515V0 (it) Dispositivo simmetropredeterminatore per la riproduzione del tracciato dell'arcata dentale

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PENWEST PHARMACEUTICALS CO., PATTERSON, N.Y., US

8364 No opposition during term of opposition